Condition: Solid Tumor · Advanced Solid Tumor · Metastatic Solid Tumor · Sponsor: Lei Zheng
This is a study that will enroll patients with cancer who have tumors that may have spread. The patients will know what medication they are being given. There will be 2 parts to the study. For the first part of the study only one medication will be taken, and the dose changed to a higher dose over time. In the second part of the study tow medications will be taken and the dose of the medication may be changed to a higher dose.
This description comes directly from the study's public registry record.
John Sarantopoulos, MD · 210 450 5946 · sarantopoulo@uthscsa.edu
Epp Goodwin · 210 450 5798 · GOODWINE@uthscsa.edu
Always discuss trial participation with your own doctor first.
| University of Texas Health Science Center at San Antonio | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07086768